CRISPR THERAPEUTICS AG Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
CRISPR THERAPEUTICS AG (CRSP) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $2.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2026-02-12
- CRISPR THERAPEUTICS AG unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2025 was $2.20M.
- CRISPR THERAPEUTICS AG unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2023 was $91.00K.
- CRISPR THERAPEUTICS AG unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2021 was $483.00K, a 80.22% increase from fiscal 2020.
- CRISPR THERAPEUTICS AG unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2020 was $268.00K.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $2.20M 10-K · filed 2026-02-12 |
| 2023-12-31 | $91.00K 10-K · filed 2026-02-12 |
| 2021-12-31 | $483.00K 10-K · filed 2024-02-21 |
| 2020-12-31 | $268.00K 10-K · filed 2023-02-21 |
| 2016-12-31 | $20.00K 10-K · filed 2019-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |